SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II Clinical Trial of ...
The study, published in Nature Medicine, found that people who experienced multiple shingles outbreaks had a measurably ...
Researchers have identified in a new study that patients suffering from chronic obstructive pulmonary disease (COPD) who ...
A new study suggests that the shingles vaccine may help prevent dementia by reducing the risk of varicella-zoster virus ...
Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Varicella Zoster Virus Infection Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
The shingles vaccine is intended to prevent shingles, but a new study suggests that it could have major secondary benefits.
A review of 155 scientific studies found influenza and COVID infections raised the risk of heart attack or stroke as much as ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...
One in every nine patients tested for viral infections across India between January and June 2025 was found positive for ...
DPA International on MSN
Flu and Covid-19 increase the risk of heart attack and stroke
Influenza and coronavirus infections markedly raise the short-term risk of acute cardiovascular disease, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback